Milestone Scientific Inc ( (MLSS) ) has released its Q3 earnings. Here is a breakdown of the information Milestone Scientific Inc presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Milestone Scientific Inc., a Delaware-based company, specializes in the development and commercialization of computer-controlled anesthetic delivery devices for dental and medical applications. The company operates primarily in the medical technology sector, with products like the CompuDent® and CompuFlo® systems that are marketed globally.
In its latest earnings report for the quarter ended September 30, 2025, Milestone Scientific Inc. reported a net loss of approximately $1.15 million, a slight improvement from the $1.46 million loss in the same period last year. The company continues to face challenges in achieving profitability, with ongoing efforts to expand its dental and medical device markets.
Key financial highlights include a decrease in total revenue to $2.36 million from $2.51 million in the previous year, alongside a reduction in operating expenses from $3.31 million to $2.78 million. Despite these efforts, the company reported a net loss per share of $0.01. The company also noted an increase in accounts payable and a decrease in cash reserves, highlighting the need for additional capital to sustain operations.
Looking ahead, Milestone Scientific Inc. remains focused on increasing revenue from its dental and medical segments while managing operating expenses. The management is actively seeking additional funding to support its operations and drive future growth, although challenges remain in securing financing on favorable terms.